Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
ANG ROBERT | PRESIDENT AND CEO, Director | C/O VOR BIOPHARMA INC., 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE | /s/ Katie Kazem, Attorney-in-Fact | 2025-05-02 | 0001741283 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VOR | Common Stock | Tax liability | -$1.82K | -2.75K | -0.3% | $0.66 | 916K | May 1, 2025 | Direct | F1 |
transaction | VOR | Common Stock | Tax liability | -$1.66K | -2.52K | -0.28% | $0.66 | 914K | May 1, 2025 | Direct | F1 |
Id | Content |
---|---|
F1 | Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. |